151 related articles for article (PubMed ID: 27177225)
1. HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.
Li A; Liu Z; Li M; Zhou S; Xu Y; Xiao Y; Yang W
Oncotarget; 2016 Jun; 7(25):37966-37978. PubMed ID: 27177225
[TBL] [Abstract][Full Text] [Related]
2. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 5 promotes the proliferation and invasion of lung cancer cells.
Zhong L; Sun S; Yao S; Han X; Gu M; Shi J
Oncol Rep; 2018 Oct; 40(4):2224-2232. PubMed ID: 30066893
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.
Wanek J; Gaisberger M; Beyreis M; Mayr C; Helm K; Primavesi F; Jäger T; Di Fazio P; Jakab M; Wagner A; Neureiter D; Kiesslich T
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321986
[TBL] [Abstract][Full Text] [Related]
5. HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women.
Oltra SS; Cejalvo JM; Tormo E; Albanell M; Ferrer A; Nacher M; Bermejo B; Hernando C; Chirivella I; Alonso E; Burgués O; Peña-Chilet M; Eroles P; Lluch A; Ribas G; Martinez MT
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32050699
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
8. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition.
Zhang M; Pan Y; Dorfman RG; Chen Z; Liu F; Zhou Q; Huang S; Zhang J; Yang D; Liu J
Oncotarget; 2016 Apr; 7(16):22285-94. PubMed ID: 26993777
[TBL] [Abstract][Full Text] [Related]
9. HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells.
Hsieh TH; Hsu CY; Tsai CF; Long CY; Wu CH; Wu DC; Lee JN; Chang WC; Tsai EM
Mol Ther; 2015 Apr; 23(4):656-66. PubMed ID: 25531695
[TBL] [Abstract][Full Text] [Related]
10. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.
Park SY; Jun JA; Jeong KJ; Heo HJ; Sohn JS; Lee HY; Park CG; Kang J
Oncol Rep; 2011 Jun; 25(6):1677-81. PubMed ID: 21455583
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.
Li XM; Liu WL; Chen X; Wang YW; Shi DB; Zhang H; Ma RR; Liu HT; Guo XY; Hou F; Li M; Gao P
Int J Mol Med; 2017 Apr; 39(4):927-935. PubMed ID: 28259959
[TBL] [Abstract][Full Text] [Related]
13. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.
Milde T; Oehme I; Korshunov A; Kopp-Schneider A; Remke M; Northcott P; Deubzer HE; Lodrini M; Taylor MD; von Deimling A; Pfister S; Witt O
Clin Cancer Res; 2010 Jun; 16(12):3240-52. PubMed ID: 20413433
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 5 promotes Wilms' tumor cell proliferation through the upregulation of c-Met.
Cao X; Liu DH; Zhou Y; Yan XM; Yuan LQ; Pan J; Fu MC; Zhang T; Wang J
Mol Med Rep; 2016 Mar; 13(3):2745-50. PubMed ID: 26847592
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
17. MiR-2861 Behaves as a Biomarker of Lung Cancer Stem Cells and Regulates the HDAC5-ERK System Genes.
Zhao M; Li L; Zhou J; Cui X; Tian Q; Jin Y; Zhu Y
Cell Reprogram; 2018 Apr; 20(2):99-106. PubMed ID: 29620443
[TBL] [Abstract][Full Text] [Related]
18. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
19. Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition.
Hendrick E; Peixoto P; Blomme A; Polese C; Matheus N; Cimino J; Frère A; Mouithys-Mickalad A; Serteyn D; Bettendorff L; Elmoualij B; De Tullio P; Eppe G; Dequiedt F; Castronovo V; Mottet D
Oncogene; 2017 Aug; 36(34):4859-4874. PubMed ID: 28414307
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P
J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
